Core Scientific shareholders on Thursday voted down an all-stock acquisition offer from partner and competitor CoreWeave that was valued at the time at $9 billion. They did so following a vote-no ...

Alfred Wilson-Spencer receives funding from the Natural Environment Research Council (NERC) grants NE/T000228/1 and NE/V010867/1. He works for the University of Leeds. The iron-rich core at the centre ...

Ladies and gentlemen, thank you for standing by. And welcome to Coursera’s First Quarter 2025 Earnings Call. All participants are in a listen-only mode and this call is being recorded. Following the ...

Kanishma Ray is a writer at GameRant, who's known to play a mean violin (decently, that is). She's a Computer Science student by day and a wordsmith by night, with a knack for crafting engaging and ...

Learning something new can feel overwhelming, especially when it comes to programming. Maybe you’ve always wanted to dip your toes into coding but felt intimidated by the jargon or unsure where to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA has granted Cour Pharmaceuticals orphan drug ...

It's been a leap-ahead year for Python—bringing on more speed, less cruft, and a large and growing user base. Credit: Pavel L Photo and Video / Shutterstock Over the course of 2024, Python has proven ...

Suzail Ahmad is a writer from Kashmir. He has been a manga and gaming enthusiast for more than a decade. As an expert, he aims to provide an in-depth analysis of titles from both mediums. When he is ...

Cour Pharmaceuticals, a local biotech startup that’s raised north of $100 million from investors, has inked a new licensing deal with a Roche subsidiary that’s valued at more than $900 million. The ...

Chicago’s Cour Pharmaceuticals—recently honored as one of Fierce Biotech’s 2024 Fierce 15—is bringing its immunology mission to the fore with a new deal featuring Swiss drug juggernaut Roche. Roche’s ...